These findings, along with the observed morphological differences and lesser growth upon CAPN2 knockdown, support the previous clinical studies and database analysis suggesting that calpain 2 is closely related to cancer cell metastatic prognosis in TNBC, but calpain 1 is not. The gene discussed is CAPN2; the disease is cancer.